LRMR

LRMR Operating Expenses

$178.99MTTM · USD

Period ending:

LRMR FY Operating ExpensesUSD
LRMR FY Operating Expenses2011-12-31: $13.15M2012-12-31: $13.78M2013-12-31: $13.77M2014-12-31: $35.53M2015-12-31: $73.74M2016-12-31: $56.91M2017-12-31: $53.69M2018-12-31: $62.46M2019-12-31: $23.21M2020-12-31: $42.65M2021-12-31: $50.47M2022-12-31: $36.53M2023-12-31: $41.76M2024-12-31: $90.89M2025-12-31: $172.50M$172.50M$0.00
2011-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

LRMR operating expenses history

Expenses from normal business operations (SG&A, R&D, etc.). The available annual fiscal periods series contains 15 observations from Dec 31, 2011 to Dec 31, 2025.

Larimar Therapeutics Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
172,497,000
90,890,000
41,758,000
36,526,000
50,465,000
42,649,000
23,214,000
62,461,000
53,687,000
56,910,000
73,743,000
35,532,000
13,768,000
13,780,000
13,150,000

Compare operating expenses

All LRMR financial metrics · LRMR stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.